Literature DB >> 23744877

Benign breast disease, mammographic breast density, and the risk of breast cancer.

Jeffrey A Tice1, Ellen S O'Meara, Donald L Weaver, Celine Vachon, Rachel Ballard-Barbash, Karla Kerlikowske.   

Abstract

BACKGROUND: Benign breast disease and high breast density are prevalent, strong risk factors for breast cancer. Women with both risk factors may be at very high risk.
METHODS: We included 42818 women participating in the Breast Cancer Surveillance Consortium who had no prior diagnosis of breast cancer and had undergone at least one benign breast biopsy and mammogram; 1359 women developed incident breast cancer in 6.1 years of follow-up (78.1% invasive, 21.9% ductal carcinoma in situ). We calculated hazard ratios (HRs) using Cox regression analysis. The referent group was women with nonproliferative changes and average density. All P values are two-sided.
RESULTS: Benign breast disease and breast density were independently associated with breast cancer. The combination of atypical hyperplasia and very high density was uncommon (0.6% of biopsies) but was associated with the highest risk for breast cancer (HR = 5.34; 95% confidence interval [CI] = 3.52 to 8.09, P < .001). Proliferative disease without atypia (25.6% of biopsies) was associated with elevated risk that varied little across levels of density: average (HR = 1.37; 95% CI = 1.11 to 1.69, P = .003), high (HR = 2.02; 95% CI = 1.68 to 2.44, P < .001), or very high (HR = 2.05; 95% CI = 1.54 to 2.72, P < .001). Low breast density (4.5% of biopsies) was associated with low risk (HRs <1) for all benign pathology diagnoses.
CONCLUSIONS: Women with high breast density and proliferative benign breast disease are at very high risk for future breast cancer. Women with low breast density are at low risk, regardless of their benign pathologic diagnosis.

Entities:  

Mesh:

Year:  2013        PMID: 23744877      PMCID: PMC3714021          DOI: 10.1093/jnci/djt124

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  41 in total

1.  Chemoprevention of breast cancer: recommendations and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

2.  Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010.

Authors:  Erika A Waters; Timothy S McNeel; Worta McCaskill Stevens; Andrew N Freedman
Journal:  Breast Cancer Res Treat       Date:  2012-05-24       Impact factor: 4.872

3.  Effects of mammographic density and benign breast disease on breast cancer risk (United States).

Authors:  C Byrne; C Schairer; L A Brinton; J Wolfe; N Parekh; M Salane; C Carter; R Hoover
Journal:  Cancer Causes Control       Date:  2001-02       Impact factor: 2.506

4.  Mammographic breast density and family history of breast cancer.

Authors:  Elad Ziv; John Shepherd; Rebecca Smith-Bindman; Karla Kerlikowske
Journal:  J Natl Cancer Inst       Date:  2003-04-02       Impact factor: 13.506

5.  Breast cancer risk assessment in 64,659 women at a single high-volume mammography clinic.

Authors:  John T Brinton; Lora D Barke; Mary E Freivogel; Stacy Jackson; Colin I O'Donnell; Deborah H Glueck
Journal:  Acad Radiol       Date:  2011-11-03       Impact factor: 3.173

6.  Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.

Authors:  Nicolien T van Ravesteyn; Diana L Miglioretti; Natasha K Stout; Sandra J Lee; Clyde B Schechter; Diana S M Buist; Hui Huang; Eveline A M Heijnsdijk; Amy Trentham-Dietz; Oguzhan Alagoz; Aimee M Near; Karla Kerlikowske; Heidi D Nelson; Jeanne S Mandelblatt; Harry J de Koning
Journal:  Ann Intern Med       Date:  2012-05-01       Impact factor: 25.391

7.  Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study.

Authors:  David L Page; Peggy A Schuyler; William D Dupont; Roy A Jensen; W Dale Plummer; Jean F Simpson
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

8.  Reported mammographic density: film-screen versus digital acquisition.

Authors:  Jennifer A Harvey; Charlotte C Gard; Diana L Miglioretti; Bonnie C Yankaskas; Karla Kerlikowske; Diana S M Buist; Berta A Geller; Tracy L Onega
Journal:  Radiology       Date:  2012-12-18       Impact factor: 11.105

9.  A breast cancer prediction model incorporating familial and personal risk factors.

Authors:  Jonathan Tyrer; Stephen W Duffy; Jack Cuzick
Journal:  Stat Med       Date:  2004-04-15       Impact factor: 2.373

10.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

View more
  54 in total

1.  Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.

Authors:  Jeanne S Mandelblatt; Natasha K Stout; Clyde B Schechter; Jeroen J van den Broek; Diana L Miglioretti; Martin Krapcho; Amy Trentham-Dietz; Diego Munoz; Sandra J Lee; Donald A Berry; Nicolien T van Ravesteyn; Oguzhan Alagoz; Karla Kerlikowske; Anna N A Tosteson; Aimee M Near; Amanda Hoeffken; Yaojen Chang; Eveline A Heijnsdijk; Gary Chisholm; Xuelin Huang; Hui Huang; Mehmet Ali Ergun; Ronald Gangnon; Brian L Sprague; Sylvia Plevritis; Eric Feuer; Harry J de Koning; Kathleen A Cronin
Journal:  Ann Intern Med       Date:  2016-01-12       Impact factor: 25.391

2.  Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer.

Authors:  Kathy A Toy; Rajeshwari R Valiathan; Fernando Núñez; Kelley M Kidwell; Maria E Gonzalez; Rafael Fridman; Celina G Kleer
Journal:  Breast Cancer Res Treat       Date:  2015-02-10       Impact factor: 4.872

3.  Dietary intake from birth through adolescence in relation to risk of benign breast disease in young women.

Authors:  Catherine S Berkey; Rulla M Tamimi; Walter C Willett; Bernard Rosner; Martha Hickey; Adetunji T Toriola; A Lindsay Frazier; Graham A Colditz
Journal:  Breast Cancer Res Treat       Date:  2019-06-20       Impact factor: 4.872

4.  Digital Breast Tomosynthesis: Radiologist Learning Curve.

Authors:  Diana L Miglioretti; Linn Abraham; Christoph I Lee; Diana S M Buist; Sally D Herschorn; Brian L Sprague; Louise M Henderson; Anna N A Tosteson; Karla Kerlikowske
Journal:  Radiology       Date:  2019-02-26       Impact factor: 11.105

5.  Changes in breast cancer risk distribution among Vermont women using screening mammography.

Authors:  Kenyon C Bolton; John L Mace; Pamela M Vacek; Sally D Herschorn; Ted A James; Jeffrey A Tice; Karla Kerlikowske; Berta M Geller; Donald L Weaver; Brian L Sprague
Journal:  J Natl Cancer Inst       Date:  2014-06-23       Impact factor: 13.506

6.  Twenty-five years of breast cancer risk models and their applications.

Authors:  Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2015-02-26       Impact factor: 13.506

7.  Dairy intake in relation to breast and pubertal development in Chilean girls.

Authors:  Audrey J Gaskins; Ana Pereira; Daiana Quintiliano; John A Shepherd; Ricardo Uauy; Camila Corvalán; Karin B Michels
Journal:  Am J Clin Nutr       Date:  2017-04-05       Impact factor: 7.045

8.  Breast density evaluation using spectral mammography, radiologist reader assessment, and segmentation techniques: a retrospective study based on left and right breast comparison.

Authors:  Sabee Molloi; Huanjun Ding; Stephen Feig
Journal:  Acad Radiol       Date:  2015-05-29       Impact factor: 3.173

9.  Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast.

Authors:  Nehmat Houssami; Linn A Abraham; Tracy Onega; Laura C Collins; Brian L Sprague; Deirdre A Hill; Diana L Miglioretti
Journal:  Breast Cancer Res Treat       Date:  2014-05-07       Impact factor: 4.872

10.  Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.

Authors:  Jeffrey A Tice; Diana L Miglioretti; Chin-Shang Li; Celine M Vachon; Charlotte C Gard; Karla Kerlikowske
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.